FDA Warns About Silver In Over-The-Counter Drugs
This file has been annotated by JOH initially 8-21-99. His comments are in brackets, [thus]. August 19, 1999 NEW YORK (Reuters Health) - Over-the-counter drug products that contain colloidal silver or silver salts have not been shown to be safe or effective, announced the US Food and Drug Administration (FDA) on Tuesday. [Note once again, the linking of CS with silver salts. They know the two have radically different properties and metabolism. One can be dangerous, no evidence exists that the other has caused harm greater than very rare diarrhea. Guess which.] The FDA also said that the general public cannot use these types of drugs safely because adequate directions for the products could not be written. [Back to public policy again, not law. No doubt "persons" can be regulated as to what they do with what they think is their own body; what about Citizens---if there are any left] Products containing silver particles have been appearing in stores in recent years, note FDA officials. [I wonder how much that research cost?] Labels on these products include claims that the products can treat adults and children for diseases including AIDS, cancer, tuberculosis, malaria, lupus, syphilis, scarlet fever, shingles, herpes, pneumonia, typhoid, and tetanus. [No mention of Lyme or Hepatitis? They missed Candida? I have never seen a CS label which claimed anything, except the presence of additives in MSP and similar mixtures and compounds and a PPM claim---admittedly often incorrect. If anyone has seen a medical claim on a CS product, please post it on the list] But FDA officials write that such products are misbranded "when their labeling falsely suggests that there is substantial scientific evidence that the drugs are safe and effective for their intended use." [I'll bet it would be interesting to read their definition of "misbranded" and "drug". They recently tried to create a regulation that said that anything which affects human metabolism is a drug. The FDA affects my blood pressure, therefore it must be regulated as a drug. Television causes permanent physical changes in the brain. Let's let the FDA regulate television. How about thinking...that causes permanent changes in the brain too. Now they are really on to something!] According to the FDA Final Rule issued Tuesday, "a colloidal silver product for any drug use will first have to be approved by the FDA under the new drug application procedures." [Hi, Mr. shadetree CS entrepreneur...got about 100,000,000 whatever-they-are for R&D?] Use of colloidal silver solutions, where silver particles are suspended in a gelatinous base, can result in argyria, "a permanent blue-gray discoloration of the skin and deep tissues," notes the FDA. [And if they do not have include the protein...then what? And, can the FDA back-up the above statement with studies which follow their own requirem ents? The one old guy on the FDA site who turned black like the silver salts in a photo emulsion was 92 years old, and in good health.] The products in question include colloidal silver ingredients and silver salts such as silver proteins, mild silver protein, strong silver protein, silver chloride, and silver iodide. The drugs are usually in oral dosage form, but sometimes exist in topical (to be applied to the skin) and even intravenous forms. [This is the best part: "Products in question..." What is/are the question(s)? Then, "Colloidal silver ingredients..." Are you, Mr. FDA talking about silver or water? In CS, that's all there is, for any practical purpose. Come on guys, this isn't scary enough. How about some horrid dramatic pictures of results of CS use, like with the Thalomide disaster. You know, one of the many drugs you approved as safe and beneficial.] Copyright 1999 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. James Osbourne, Holmes [email protected]
<<application/ms-tnef>>

